![]()
Oventus Medical Ltd (ASX:OVN) is pleased to announce the appointment of a Medical Technology Advisory Board (MTAB) of international sleep experts to help guide the development and commercialisation of the Company's Sleep Treatment Platform.
Key points:
- Inaugural Medical Technology Advisory Board (MTAB) appointed to guide the launch of Oventus' Sleep Treatment Platform to US Sleep Professionals, as well as its further platform development
- MTAB comprises highly experienced leaders and international experts in sleep medicine, and will facilitate the introduction of Oventus Airway Technology as a new treatment option to US sleep physicians
- Clinical evidence shows that Oventus Airway Technology eliminates the need for full face masks for 100% of patients and eliminates the need for CPAP for 78% of patients;
- Having a new treatment modality with higher adherence rates than CPAP and similar success rates represents a major benefit for sleep apnoea patients
Reporting to CEO, Dr Chris Hart, the MTAB will be a US-based consultative advisory body which provides input and guidance into Oventus' clinical, developmental and commercial strategy, focused on introducing Oventus' products to the sleep channel in the United States. Members of the MTAB have been appointed with a three year term, renewable by mutual agreement.
The MTAB is composed of the following leading sleep physicians and advisors in the United States, Oventus' key market for roll-out:
- Lee A. Surkin, MD, FAASM
- Richard K. Bogan, MD, FCCP, FAASM
- Jerry Kram, MD, FAASM
- Mark Hickey, MD, FAASM
- Mark A. Rasmus, MD, FAASM
- Daniel B. Brown, Esq
- Myra G. Brown
Further background on each of the MTAB members can be found in the appendix which follows.
Dr Chris Hart, CEO of Oventus commented, "We are delighted to have attracted such a respected group of sleep experts to join this inaugural Medical Technology Advisory Board, particularly given Oventus' strong focus on establishing the market for our products within the United States' sleep medicine channel.
The formation of this Board will help drive forward the clear potential of our Sleep Treatment Platform. These professionals bring a strong mix of skills - they understand the complex business, legal and regulatory frameworks; provide clinical expertise through the supply chain and will help us ensure focus on the delivery of personalised patient care."
MTAB member Dr Lee Surkin, renowned cardiologist, boarded sleep physician and CMO of N3Sleep commented, "I have frequently sent patients to my colleague in dental sleep medicine for an oral appliance therapy to help stablize the mandible and open the airway, which very often results in reduced CPAP pressure requirements and therefore translates into improved adherence and improved treatment and outcomes.
If an oral appliance is as effective as CPAP is, I would say 'ball game over' because of the significantly improved compliance with oral appliance therapy and obviously, if it's as efficacious as CPAP, you have solved the problem."
Inline with recent announcements, clinical evidence shows that Oventus Airway Technology can now provide the same treatment outcomes as conventional CPAP technology for 78% of obstructive sleep apnoea (OSA) patients. Furthermore, clinical data indicates that with the inclusion of Oventus' CPAP Connect technology, Oventus can treat 100% of patients at reduced air pressures and without the need for a full face mask, providing a more comfortable treatment option for those patients. Having a new treatment modality with higher adherence rates than CPAP and similar success rates represents a major benefit for OSA patents.
Further information can be found on our website: http://oventus.com.au/how-it-works/
Appendix: Medical Technology Advisory Board member biographies
Dr. Lee A. Surkin, MD, FAASM
Chief Medical Officer of N3Sleep
Dr. Lee A. Surkin, MD is the Chief Medical Officer of N3Sleep. A private practitioner in cardiology, sleep medicine and obesity medicine, he is one of a small group of physicians to be triple board certified in cardiology, sleep medicine and nuclear cardiology. His professional career has evolved from practicing cardiology exclusively to a unique practice model that emphasizes a comprehensive wellness approach by incorporating sleep, cardiovascular and bariatric medicine.
In 2009, he created Carolina Sleep - the only dedicated sleep medicine practice in eastern NC. Carolina Sleep is a full-service sleep medicine practice offering in-center and home sleep testing with comprehensive clinic evaluation and management. Carolina Sleep offers a multifaceted approach to treatment including PAP therapy, Provent (1st practice in the state to offer Provent), and a medically supervised weight loss program. He has forged successful relationships with ENTs and dental sleep physicians and has demonstrated leadership by introducing new and innovative testing and treatment modalities.
Dr. Surkin has created a cardiovascular and sleep healthcare model that includes a multi-faceted diagnostic and treatment approach that is enhanced by a network of relationships with physicians, dentists, respiratory therapists, sleep technologists and public officials who recognize the important role that sleep medicine has in our daily life.
In 2012, Dr Surkin founded the American Academy of Cardiovascular Sleep Medicine which is a not-for-profit academic organization dedicated to educating healthcare providers, supporting research and increasing public awareness of the convergence between cardiovascular disease and sleep disorders. In 2014, Dr. Surkin created a new multi-specialty practice called Carolina Clinic for Health and Wellness which combines his specialties with primary care, gynecology, behavioral health and a medical spa. Dr. Surkin is married with three daughters and two dogs and resides in Greenville, NC.
Richard K. Bogan, MD, FCCP, FAASM
Richard K. Bogan, MD, FCCP, FAASM is Associate Clinical Professor at the University of South Carolina School of Medicine in Columbia, SC and Medical University of SC in Charleston, SC. He is the Chief Medical Officer and a Director of SleepMed Inc.. He is one of the founders of SleepMed, the largest sleep diagnostic company in the U.S.
Dr. Bogan received his medical degree from the Medical University of South Carolina in Charleston, South Carolina. He completed his Internal Medicine residency at the University of Alabama Hospitals and Clinics and his Pulmonary, Critical Care fellowship at the University of Alabama School of Medicine, both in Birmingham, Alabama.
Dr. Bogan is board certified in sleep medicine, pulmonary medicine and internal medicine with previous certification in critical care. He has served as the medical director for several hospital departments and serves on various business, community, and civic boards. He has dedicated the majority of his medical career to creating standards of excellence in sleep disease management. In addition to operating a Columbia-based, 9-bed, accredited sleep centre, he has been involved in numerous clinical research trials and has published numerous articles in sleep medicine. He has been a consultant to the pharmaceutical and device industry and has lectured in international, regional and national meetings.
Jerrold A. Kram, MD, FCCP, FAASM
Medical Director of the California Center for Sleep Disorders
Dr. Jerry Kram is the medical director of the California Center for Sleep Disorders which he founded in 1980 as one of the first free standing centers in the country and now has 8 locations.
He received his medical degree from New York University School of Medicine graduating with honors. He then went to the University of California San Francisco where he trained in Internal Medicine, Clinical Pharmacology and Pulmonary Medicine.
He is board certified in internal medicine, pulmonary medicine and sleep medicine. He has lectured extensively around the country on sleep disorders helping to advance the awareness of sleep disorders. He has conducted many clinical trials of treatments for various sleep disorders and published articles and chapters on this topic.
He is on the faculty of the School of Sleep Medicine at Samuel Merritt University and a member of the Board of the National Sleep Foundation. He lives in Northern California with his wife and has 5 children and 9 grandchildren.
Mark Hickey, MD, FAASM
Founder, Colorado Sleep Institute
Dr. Hickey is the founder of the Colorado Sleep Institute (formerly Rem Sleep Medicine PC), which was established in 2010 to provide truly comprehensive care for the full spectrum of sleep disorders.
Dr. Hickey is a Mayo-trained Neurologist and is both fellowship-trained & board-certified in Sleep Medicine. He is devoted to the full-time practice of Sleep Medicine.
After graduating from the University of South Florida College of Medicine Dr. Hickey pursued a residency in adult Neurology at Mayo Clinic Arizona. Thereafter he completed a fellowship program in Sleep Medicine at Louisiana State University Health Sciences Center in Shreveport.
Dr. Hickey was an Assistant Professor of Sleep Medicine in the Department of Neurology at Louisiana State University Health Sciences Center prior to founding the Colorado Sleep Institute in 2010.
At the American Academy of Sleep Medicine, Dr. Hickey serves in three capacities: consultant to the AASM Health Policy Strategy Presidential Committee, Welltrinsic Board member, and AASM legislative liaison. At the Boulder Valley Individual Practice Association, he is both a Board member and Credentials Committee member. At the Boulder Valley Care Network, he serves as a Board member. He is an active member of the Colorado Medical Society and Boulder County Medical Society.
When not working, Dr. Hickey enjoys spending time with his family camping, hiking and fishing.
Mark A. Rasmus, MD, FAASM
Medical Director, Idaho Sleep Health
Dr. Mark Rasmus, Medical Director of Idaho Sleep Health, obtained his bachelor's degree from Dartmouth College and his medical degree from St. George's University School of Medicine. He completed a combined residency in internal medicine and pediatrics through Albany Medical Center in New York, followed by a pulmonary/critical care fellowship at the University of Utah and a sleep medicine fellowship at LDS Hospital in Salt Lake City, Utah. Dr. Rasmus is board certified in pediatrics, internal medicine, pulmonary medicine, critical care and sleep medicine.
Dedicated to public education about sleep matters, Dr. Rasmus has appeared on television and frequently speaks to community groups and physicians. He has conducted clinical research and has published articles in sleep disordered breathing and CPAP humidification. Further research projects focused on the relationship between cardiovascular disorders and sleep disordered breathing. His expertise allows the Idaho Sleep Health staff to deliver the best possible care to patients of all ages with sleep disorders.
On a national level, Dr. Rasmus is a member of the American Academy of Sleep Medicine, the American College of Chest Physicians, the American College of Physicians and the Society of Critical Care Medicine. In 2007 he was awarded an appointment at the University of Washington Department of Medicine as a Clinical Instructor.
In his free time, Dr. Rasmus enjoys skiing, white-water kayaking, mountain biking, rock climbing, hiking, gourmet cooking and traveling.
Daniel B. Brown, Esq.
Partner, Healthcare and Corporate Practice Groups, Taylor English Duma LLP Atlanta, Georgia.
Dan is an accomplished corporate and healthcare attorney who regularly advises clients on the legal and regulatory aspects associated with the operation and sale of heath care businesses.
He represents a variety of sleep medicine providers, durable medical equipment suppliers, medical device manufacturers, physician groups, health care franchisors and health systems on structuring health care business operations and maintaining regulatory compliance with the Stark laws, Anti-Kickback Laws and HIPAA. An experienced corporate lawyer, Dan advises health care providers in mergers, asset acquisitions, and joint ventures. He is a frequent speaker and author on the legal aspects of sleep medicine, home medical equipment, and other health law matters.
Dan served as Treasurer and a member of the Executive Committee of the National Sleep Foundation. He is on the Faculty of the Atlanta School of Sleep Medicine and Technology and on the Editorial Advisory Board of Sleep Review Magazine.
He is a member of the American Academy of Sleep Medicine, the American Health Lawyers Association, and the Health Law Section of the Georgia State Bar.
Myra G. Brown
President, MBrownGroup LLC
Myra has more than 30 years of experience managing, consulting, directing and developing business opportunities for health care companies, device manufacturers, health insurers, entrepreneurs, and individual health care providers. She received an MBA in Healthcare Administration from the Wharton School, University of Pennsylvania, and began her career with Hospital Corporation of America (HCA). She later served as the Chief Operating Office of The Bill Wilkerson Center of Vanderbilt University.
After relocating with her family from Nashville to Atlanta, Myra established her consulting practice, where she works developing strategic business, branding and marketing plans for companies ranging from new business start-ups to multinational entities. For the past 12 years, she has focused on the consumer sleep market, interacting with the media, engaging with consumers, retailers and providers through product development, branding, licensing, public relations and social media.
For 8 years she served as president and cofounder of License to Sleep, a product and brand licensing company offering scientific development and professional endorsement of a wide array of sleep products and services.
Myra and her husband are parents of three adult daughters and are avid Atlanta Braves fans. They live in Sandy Springs, GA.
To view figures, please visit:
http://abnnewswire.net/lnk/94159Z6C
Dr Chris Hart
Managing Director and CEO
M: +61-409-647-496
Jane Lowe
IR Department
M: +61-411-117-774 or
E: jane.lowe@irdepartment.com.au
Intermin Resources Limited (ASX:IRC) ("Intermin" or "the Company") is pleased to advise that today it has completed the issue of 3,226,345 fully paid ordinary shares after receiving final option exercise forms and payments totalling $548,478. 
Alligator Energy Limited (ASX:AGE) (Alligator or the Company) is pleased to advise that its exploration team and drilling contractor (DDH1) have commenced exploration drilling operations at its TCC4 uranium prospect in the Alligator Rivers Uranium Province (ARUP) in Arnhem Land, Northern Territory. 
Goldfields Money Limited (ASX:GMY) ("Goldfields Money" or the "Company") is pleased to announce that it has received binding commitments from international and local institutional and professional investors to successfully raise gross proceeds of ~$20.0 million by way of a placement of new fully paid ordinary shares ("Placement"). 
Venus Metals Corporation Limited (ASX:VMC) (Company) has entered into a convertible loan agreement dated 3 September 2018 with Bazco Pty Ltd (Bazco), an entity controlled by Mr Barry Fehlberg, an Executive Director of the Company, pursuant to which Bazco will advance A$400,000 (Principal) to the Company (Convertible Loan). Further details of the Convertible Loan are set out below. 
State Gas Limited (ASX:GAS) provides the Company's Annual Report to shareholders. 
In this segment of The Ellis Martin Report, John Anderson, Chairman of Triumph Gold Corp (CVE:TIG)(OTCMKTS:TIGCF) discusses the company's intersection of strong Gold-Rich Porphyry mineralization in the Blue Sky Porphyry, including 125.13 metres of 1.23 grams per tonne gold, 0.31% copper. What lies ahead potentially for Triumph in the Yukon? 
Ardea Resources Ltd (ASX:ARL) (OTCMKTS:ARRRF) announces exceptional gold-silver rock chip results at Black Bullock Prospect, NSW. 
Argentine-focused lithium exploration and project development company Lake Resources NL (ASX:LKE) and Lilac Solutions, Inc. ("Lilac") are pleased to announce a significant step forward in the development of Lake's 100%-owned Kachi Lithium Brine Project in Argentina ("Kachi"). 
Emerging Australian lithium developer, Core Exploration Ltd (ASX:CXO) ("Core" or the "Company") is pleased to announce that it has appointed Argonaut as a financial adviser. 
Altech Chemicals Limited (Altech/the Company) (ASX:ATC) (FRA:A3Y) is pleased to advise that a geotechnical ground drilling and survey program that commenced in mid-August 2018 at the site of its proposed high purity alumina (HPA) plant in Johor, Malaysia is well advanced and nearing completion. 
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) ("MMJ") is pleased to note the attached three news releases by MediPharm Labs Inc ("MediPharm") providing the details of three customer contracts signed over the past month or so and ahead of its listing on the TSX Venture Exchange ("TSX-V") expected later this month. 
Anti-counterfeit and customer engagement solutions provider YPB Group Ltd (ASX:YPB) is pleased that Bluey Merino will employ YPB's ProtectCode solution suite as its anti-counterfeit and customer engagement strategy ahead of its push into export markets. 
Cobalt Blue Holdings Limited (ASX:COB) (OTCMKTS:CBBHF) advises that it has received notice from Broken Hill Prospecting Limited (ASX:BPL) (OTCMKTS:BPLNF) that BPL has accepted to its satisfaction the completion of the Stage Two earning obligations under the Joint Venture Agreement on the Thackaringa Cobalt Project in Broken Hill NSW. BPL advised that it completed a rigorous review of the TJV Stage Two deliverables. Accordingly COB now formally announces the following beneficial ownership over the Thackaringa tenements: 
The Directors of Venus Metals Corporation Limited (ASX:VMC) ("Venus" or the "Company") are pleased to announce a major breakthrough in regard to the Youanmi Vanadium Project following receipt of proof-of-concept metallurgical test work on oxide ores. 
Australian Securities Exchange and Frankfurt Stock Exchange cross listed iSignthis Ltd (ASX:ISX) (FRA:TA8) (the Company") is pleased to announce that it has entered into terms to acquire 100% of the issued capital of an EU based core banking platform software business ("the Business"). 
In this segment of the Ellis Martin Report, Harry Barr, the Chairman of New Age Metals (CVE:NAM) (OTCMKTS:NMTLF) discusses the company's completion of the Genesis PGM/Polymettalic Technical Report for the Drill Ready/Road Accessible Alaskan Project. 
On 1 August 2018 the ASX issued a query letter (Query Letter) to Byte Power Group Limited (ASX:BPG) (BPG). 
Oventus Medical Ltd (ASX:OVN) is pleased to announce the appointment of a Medical Technology Advisory Board (MTAB) of international sleep experts to help guide the development and commercialisation of the Company's Sleep Treatment Platform. 
Regeneus Ltd (ASX:RGS) (Regeneus or the company), a clinical-stage regenerative medicine company, today reported that it has received $2.4m from the Australian Government's Research and Development tax incentive program for activities conducted during the financial year 2018. 
Emmerson (ASX:ERM) (OTCMKTS:EMMRF) secures Strategic Alliance with TRL Tennant Creek Pty Ltd (a subsidiary of Territory Resources Ltd) (TTY) that includes a Mining and Exploration Joint Venture covering the Southern Project Area (SPA) at Tennant Creek. 
